신경혈관 카테터 시장 규모, 점유율, 성장 분석 : 유형별, 컴포넌트별, 용도별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)

Neurovascular Catheters Market size was valued at USD 3.25 billion in 2023 and is poised to grow from USD 3.48 billion in 2024 to USD 6.08 billion by 2032, growing at a CAGR of 7.2% during the forecast period (2025-2032).

Market insights indicate robust growth in the neurovascular sector, driven by increasing incidences of neurological disorders such as brain aneurysms and strokes, alongside unhealthy lifestyle choices and heightened public awareness regarding treatment options. The global incidence of subarachnoid hemorrhage (SAH) stands at approximately 6.67 per 100,000 individuals, with over 500,000 affected annually, predominantly in low- and middle-income regions. Furthermore, technological advancements, particularly in neurovascular catheter technology, are set to fuel market expansion. Notably, CERENOVUS launched the EMBOGUARD catheter for endovascular procedures in February 2022, enhancing treatment efficacy for acute ischemic strokes. Research continues to affirm the safety and effectiveness of various neurovascular access methodologies, paving the way for innovative solutions and contributing to the anticipated market growth during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Catheters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Catheters Market Segments Analysis

Global Neurovascular Catheters Market is segmented by Type, Component, Application, End-use and region. Based on Type, the market is segmented into Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters and Others. Based on Component, the market is segmented into Catheter Mandrels, Catheter Liners, Reflow Heat Shrinks, Nylon Tubing/Pebax and Other Components. Based on Application, the market is segmented into Embolic Stroke, Brain Aneurysm, Arteriovenous Malformations and Others. Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Catheters Market

The growing incidence of neurological conditions, including strokes, aneurysms, and arteriovenous malformations (AVMs), significantly contributes to the rising demand for neurovascular catheters. These specialized catheters play a crucial role in both the diagnosis and treatment of such disorders. As the number of individuals affected by these neurological issues continues to rise, the need for effective intervention tools like neurovascular catheters becomes increasingly critical, thereby fueling market growth. This upward trend in neurological disorders underscores the essential nature of these medical devices and propels the demand for advancements and innovations within the neurovascular catheter market.

Restraints in the Neurovascular Catheters Market

The neurovascular catheters market faces significant challenges due to the potential complications associated with their use. Operating within the intricate network of blood vessels in the brain presents risks such as bleeding, clotting, vessel perforation, and infections. These complications can result in serious neurological impairments or, in extreme cases, fatalities. Additionally, they may prolong hospital stays and escalate healthcare expenses. Patients with pre-existing medical conditions are particularly susceptible to these risks, further complicating the clinical landscape. Consequently, such factors can act as restraints on the growth and adoption of neurovascular catheters in clinical practices.

Market Trends of the Neurovascular Catheters Market

The neurovascular catheters market is experiencing robust growth, propelled by the rising prevalence of neurological disorders such as strokes, aneurysms, and arteriovenous malformations. The World Health Organization (WHO) highlights that stroke ranks as the second leading cause of death worldwide, intensifying the urgency for advanced therapeutic solutions. An increasing aging population, coupled with greater awareness and diagnosis of neurological conditions, is further driving market demand. Innovations in catheter technology, including enhanced navigation and precision delivery systems, are also shaping the market landscape. Together, these dynamics position the neurovascular catheters market for substantial growth in the coming years, as healthcare providers seek effective interventions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Neurovascular Catheters Market Size by Type & CAGR (2025-2032)

• Market Overview
• Microcatheters
• Balloon Catheters
• Access Catheters
• Embolization Catheters
• Others

Global Neurovascular Catheters Market Size by Component & CAGR (2025-2032)

• Market Overview
• Catheter Mandrels
• Catheter Liners
• Reflow Heat Shrinks
• Nylon Tubing/Pebax
• Other Components

Global Neurovascular Catheters Market Size by Application & CAGR (2025-2032)

• Market Overview
• Embolic Stroke
• Brain Aneurysm
• Arteriovenous Malformations
• Others

Global Neurovascular Catheters Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers

Global Neurovascular Catheters Market Size & CAGR (2025-2032)

• North America (Type, Component, Application, End-use)
  • US
  • Canada
• Europe (Type, Component, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Component, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Component, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Component, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Galway, Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (Marlborough, Massachusetts, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (Kalamazoo, Michigan, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra (Alameda, California, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (Irvine, California, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Tokyo, Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (New Brunswick, New Jersey, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (Abbott Park, Illinois, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen (Melsungen, Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific (Shanghai, China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (Plano, Texas, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (Bloomington, Indiana, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (Dublin, Ohio, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (London, United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (Wayne, Pennsylvania, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (South Jordan, Utah, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Osaka, Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc (Aichi, Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates (Newark, Delaware, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec (London, United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations